Saline antitrust claims are “quite implausible”, judge says

A judge has dismissed without prejudice claims that Baxter and Hospira conspired to increase the price of intravenous saline solution by falsely recalling the product and depleting the saline inventory nationwide.

Get unlimited access to all Global Competition Review content